Atalanta Sosnoff Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $93.5M | Sell |
77,995
-53,516
| -41% | -$54.7M | 1.65% | 22 |
|
|
2026
Q1 | $121M | Sell |
131,511
-385
| -0.3% | -$390K | 2.6% | 9 |
|
|
2025
Q4 | $142M | Sell |
131,896
-1,413
| -1% | -$1.35M | 2.76% | 9 |
|
|
2025
Q3 | $102M | Sell |
133,309
-2,903
| -2% | -$2.16M | 1.95% | 16 |
|
|
2025
Q2 | $106M | Buy |
136,212
+405
| +0.3% | +$315K | 2.16% | 13 |
|
|
2025
Q1 | $112M | Buy |
135,807
+16
| +0% | +$13.3K | 2.68% | 9 |
|
|
2024
Q4 | $105M | Sell |
135,791
-2,896
| -2% | -$2.4M | 2.28% | 10 |
|
|
2024
Q3 | $123M | Sell |
138,687
-17,805
| -11% | -$16M | 2.64% | 8 |
|
|
2024
Q2 | $142M | Sell |
156,492
-4,622
| -3% | -$3.7M | 3.2% | 7 |
|
|
2024
Q1 | $125M | Sell |
161,114
-6,076
| -4% | -$4.32M | 2.9% | 8 |
|
|
2023
Q4 | $97.5M | Sell |
167,190
-5,468
| -3% | -$3.19M | 2.51% | 8 |
|
|
2023
Q3 | $92.7M | Sell |
172,658
-49,218
| -22% | -$25.4M | 2.75% | 8 |
|
|
2023
Q2 | $104M | Sell |
221,876
-6,063
| -3% | -$2.54M | 2.82% | 7 |
|
|
2023
Q1 | $78.3M | Buy |
227,939
+25,827
| +13% | +$8.71M | 2.27% | 10 |
|
|
2022
Q4 | $73.9M | Sell |
202,112
-26,719
| -12% | -$9.47M | 2.28% | 11 |
|
|
2022
Q3 | $74M | Sell |
228,831
-3,534
| -2% | -$1.12M | 2.33% | 15 |
|
|
2022
Q2 | $75.3M | Buy |
232,365
+77,298
| +50% | +$23.2M | 2.27% | 11 |
|
|
2022
Q1 | $44.4M | Buy |
155,067
+6,099
| +4% | +$1.57M | 1.04% | 38 |
|
|
2021
Q4 | $41.1M | Buy |
148,968
+256
| +0.2% | +$64.9K | 0.89% | 41 |
|
|
2021
Q3 | $34.4M | Buy |
148,712
+1,431
| +1% | +$353K | 0.8% | 41 |
|
|
2021
Q2 | $33.8M | Sell |
147,281
-1,439
| -1% | -$289K | 0.78% | 41 |
|
|
2021
Q1 | $27.8M | Sell |
148,720
-238,584
| -62% | -$46.7M | 0.69% | 47 |
|
|
2020
Q4 | $65.4M | Sell |
387,304
-23,656
| -6% | -$3.53M | 1.67% | 22 |
|
|
2020
Q3 | $60.8M | Sell |
410,960
-8,500
| -2% | -$1.32M | 1.72% | 18 |
|
|
2020
Q2 | $68.9M | Sell |
419,460
-5,669
| -1% | -$870K | 2.08% | 14 |
|
|
2020
Q1 | $59M | Buy |
425,129
+126,054
| +42% | +$17.3M | 2.1% | 14 |
|
|
2019
Q4 | $39.3M | Sell |
299,075
-2,870
| -1% | -$333K | 1.17% | 37 |
|
|
2019
Q3 | $33.8M | Sell |
301,945
-231,159
| -43% | -$25.7M | 1.09% | 41 |
|
|
2019
Q2 | $59.1M | Sell |
533,104
-16,821
| -3% | -$1.98M | 1.86% | 20 |
|
|
2019
Q1 | $71.4M | Sell |
549,925
-27,860
| -5% | -$3.39M | 2.23% | 12 |
|
|
2018
Q4 | $66.9M | Buy |
577,785
+219,347
| +61% | +$24.5M | 2.43% | 11 |
|
|
2018
Q3 | $38.5M | Buy |
+358,438
| New | +$35.8M | 1.15% | 37 |
|
|
2018
Q2 | – | Sell |
-23,764
| Closed | -$1.84M | – | 77 |
|
|
2018
Q1 | $1.84M | Sell |
23,764
-126
| -0.5% | -$10.1K | 0.06% | 60 |
|
|
2017
Q4 | $2.02M | Sell |
23,890
-314
| -1% | -$26.7K | 0.07% | 61 |
|
|
2017
Q3 | $2.07M | Sell |
24,204
-481,459
| -95% | -$39.5M | 0.07% | 60 |
|
|
2017
Q2 | $41.6M | Buy |
505,663
+65,874
| +15% | +$5.37M | 1.47% | 27 |
|
|
2017
Q1 | $37M | Buy |
439,789
+154,097
| +54% | +$12.3M | 1.3% | 32 |
|
|
2016
Q4 | $21M | Sell |
285,692
-43,201
| -13% | -$3.22M | 0.75% | 53 |
|
|
2016
Q3 | $26.4M | Buy |
+328,893
| New | +$26.3M | 0.91% | 47 |
|
Other funds holding LLY
Atalanta Sosnoff Capital's LLY Position: Q2 2026 in Review
Atalanta Sosnoff Capital reduced its Eli Lilly (LLY) stake by 41% in Q2 2026, selling an estimated $54.7M and leaving 77,995 shares worth $93.5M. The position accounts for 1.65% of the portfolio, ranked #22.
Atalanta Sosnoff Capital first reported a position in LLY in Q3 2016 and has held it in 39 quarters since. The position peaked at $142M in Q4 2025. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Atalanta Sosnoff Capital held 77,995 shares of Eli Lilly worth $93.5M as of Q2 2026.
- Atalanta Sosnoff Capital sold 53,516 Eli Lilly shares in Q2 2026, an estimated $54.7M.
- Eli Lilly made up 1.65% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #22 holding.
- Atalanta Sosnoff Capital first reported a position in Eli Lilly in Q3 2016 and has held it in 39 quarters since.
- Atalanta Sosnoff Capital's Eli Lilly position peaked at $142M in Q4 2025.
- 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.